Unknown

Dataset Information

0

Purification, crystallization and preliminary X-ray analysis of the aspartate aminotransferase of Plasmodium falciparum.


ABSTRACT: Aspartate aminotransferases (EC 2.6.1.1) catalyse the conversion of aspartate and alpha-ketoglutarate to oxaloacetate and glutamate in a reversible manner. Thus, the aspartate aminotransferase of Plasmodium falciparum (PfAspAT) plays a central role in the transamination of amino acids. Recent findings suggest that PfAspAT may also play a pivotal role in energy metabolism and the de novo biosynthesis of pyrimidines. While therapeutics based upon the inhibition of other proteins in these pathways are already used in the treatment of malaria, the advent of multidrug-resistant strains has limited their efficacy. The presence of PfAspAT in these pathways may offer additional opportunities for the development of novel therapeutics. In order to gain a deeper understanding of the function and role of PfAspAT, it has been expressed and purified to homogeneity. The successful crystallization of PfAspAT, the collection of a 2.8 A diffraction data set and initial attempts to solve the structure using molecular replacement are reported.

SUBMITTER: Jain R 

PROVIDER: S-EPMC2852332 | biostudies-literature | 2010 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Purification, crystallization and preliminary X-ray analysis of the aspartate aminotransferase of Plasmodium falciparum.

Jain Rishabh R   Jordanova Rositsa R   Müller Ingrid B IB   Wrenger Carsten C   Groves Matthew R MR  

Acta crystallographica. Section F, Structural biology and crystallization communications 20100331 Pt 4


Aspartate aminotransferases (EC 2.6.1.1) catalyse the conversion of aspartate and alpha-ketoglutarate to oxaloacetate and glutamate in a reversible manner. Thus, the aspartate aminotransferase of Plasmodium falciparum (PfAspAT) plays a central role in the transamination of amino acids. Recent findings suggest that PfAspAT may also play a pivotal role in energy metabolism and the de novo biosynthesis of pyrimidines. While therapeutics based upon the inhibition of other proteins in these pathways  ...[more]

Similar Datasets

| S-EPMC3370907 | biostudies-literature
| S-EPMC4231864 | biostudies-literature
| S-EPMC2335077 | biostudies-literature
| S-EPMC4356312 | biostudies-literature
| S-EPMC2374159 | biostudies-literature
| S-EPMC2330127 | biostudies-literature
| S-EPMC3855736 | biostudies-literature
| S-EPMC2664778 | biostudies-literature
| S-EPMC3370904 | biostudies-literature
| S-EPMC2833051 | biostudies-literature